Abstract
Background
Primary thyroid lymphoma is a rare tumor that makes up 1–5% of thyroid malignancies and less than 2% of extranodal lymphomas. The treatment and prognosis of thyroid lymphomas can be divided into two distinct clinicopathologic entities: pure mucosa-associated lymphoid tissue (MALT) lymphomas and diffuse large B-cell or mixed subtypes.
Methods
An evidence-based review was performed to determine the role of fine-needle aspiration (FNA) biopsy and adjuncts as the first diagnostic test for thyroid lymphoma, the role of open surgical biopsy, the role of palliative surgery as well as the best treatment (combined chemoradiation versus single modality surgery or radiation) for thyroid lymphoma. The ideal treatment of thyroid lymphoma was further assessed for both diffuse B-cell and MALT histologic subtypes.
Results
Although an evidence-based review was challenging primarily due to a lack of high-level evidence, several recommendations are possible and presented regarding the optimal diagnostic methods and treatment of thyroid lymphoma. FNA and adjuncts are recommended as the first test to diagnose thyroid lymphoma, but open surgical biopsy may still be required in many cases. Combined chemoradiation therapy is recommended for all diffuse B-cell or mixed lymphomas. Single modality therapy with surgery or radiation alone may be considered for early-stage (IE) intrathyroidal MALT lymphomas. No recommendations could be made regarding the role of palliative surgery.
Conclusion
Evidence-based recommendations can be applied to the individual patient with thyroid lymphoma with the involvement of an experienced multidisciplinary team consisting of an endocrine/oncology surgeon, radiation oncologist, and medical oncologist.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Derringer GA, Thompson LDR, Frommelt RA, et al. Malignant lymphoma of the thyroid gland: A clinicopathologic study of 108 cases. Am J Surg Pathol 2000;24:623–639
Pedersen RK, Pedersen NT. Primary non-Hodgkin’s lymphoma of the thyroid gland: A population based study. Histopathology 1996;28:25–32
Ruggiero FP, Frauenhoffer E, Stack BC. Thyroid lymphoma: a single institution’s experience. Otolaryngol Head Neck Surg 2005;133:888–896
Ansell SM, Grant CS, Haberman TM. Primary thyroid lymphoma. Semin Oncol 1999;26:316–323
Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985;312:601
Matsuzuka F, Miyauchi A, Katayama S, et al. Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. Thyroid 1993;3:93–99
Thieblemont C, Mayer A, Dumontet C, et al. Primary lymphoma is a heterogeneous disease. J Clin Endocrinol Metab 2002;87:105–111
Doria R, Jekel JF, Cooper DL. Thyroid lymphoma: the case for combined modality therapy. Cancer 1994;73:200–206
Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1989;95:2S–4S
Cook DJ, Guyatt GH, Laupacis A, et al. Clinical recommendations using levels of evidence for antithrombotic agents. Chest 1995;108:227S–230S
Cha C, Chen H, Westra WH, et al. Primary thyroid lymphoma: can the diagnosis be made solely by fine-needle aspiration? Ann Surg Oncol 2002;9:298–302
Sangalli G, Serio G, Zampatti C, et al. Fine needle aspiration cytology of primary lymphoma of the thyroid: a report of 17 cases. Cytopathology 2001;12:257–263
Young NA, Al-Saleem T. Diagnosis of lymphoma by fine-needle aspiration cytology using the Revised European–American classification of lymphoid neoplasms. Cancer Cytopathol 1999;87:325–345
Takano T, Miyauchi A, Matsuzuka F, et al. Detection of monoclonality of the immunoglobulin heavy chain gene in thyroid malignant lymphoma by vectorette polymerase chain reaction. J Clin Endocrinol Metab 2005;90:720–723
Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphomoid tissue: a distinctive type of B-cell lymphoma. Cancer 1983;52:1410–1416
Ha CS, Shadle KM, Medeiros LJ, et al. Localized non-Hodgkin lymphoma involving the thyroid gland. Cancer 2001;91:629–635
Friedberg MH, Coburn MC, Monchik JM. Role of surgery in stage IE non-Hodgkin’s lymphoma of the thyroid. Surgery 1994;116:1061–1066
DiBiase SJ, Grigsby PW, Guo C, et al. Outcome analysis for stage IE and IIE thyroid lymphoma. Am J Clin Oncol 2004;27:178–184
Skacel M, Ross CW, Hsi ED. A reassessment of primary thyroid lymphoma: high-grade MALT-type lymphoma as a distinct subtype of diffuse large B-cell lymphoma. Histopathology 2000;37:10–18
Kuper-Hommel MJ, Snijder S, Jansen-Heijnen ML, et al. Treatment and survival of patients with thyroid lymphoma: a population-based study with clinical and pathologic reviews. Clin Lymphoma Myeloma 2005;6:240–247
Wirtzfeld DA, Winston JS, Hicks WL, et al. Clinical presentation and treatment of non-Hodgkin’s lymphoma of the thyroid gland. Ann Surg Oncol 2001;8:338–341
Singer JA. Primary lymphoma of the thyroid. Am Surg 1998;64:334–338
Sasai K, Yamabe H, Haga H, et al. Non-Hodgkin’s lymphoma of the thyroid. A clinical study of twenty-two cases. Acta Oncol 1996;35:457–462
Miller TP, Dahlberg S, Cassady JR, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate and high-grade non-Hodgkin’s lymphoma. N Engl J Med 1998;339:21–26
Horning SJ, Weller E, Kim K, et al. Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin’s lymphoma: Eastern Cooperative Oncology Group Study 1484. J Clin Oncol 2004;22:3032–3038
Reyes F, Lepage E, Ganem G, et al. ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma. N Engl J Med 2005;352:1197–1205
Levels of evidence. Retrieved September 25, 2006 from http://www.eboncall.org/content/levels.html
Pyke CM, Grant CS, Habermann TM, et al. Non-Hodgkin’s lymphoma of the thyroid: is more than biopsy necessary? World J Surg 1992;16:604–609
Junor EJ, Paul J, Reed NS. Primary non-Hodgkin’s lymphoma of the thyroid. Eur J Surg Oncol 1992;18:313–321
Zinzani PL, Magagnoli M, Galieni P, et al. Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. J Clin Oncol 1999;17:1254–1258
Laing RW, Hoskin P, Hudson BV, et al. The significance of MALT histology in thyroid lymphoma: a review of patients from the BNLI and Royal Marsden Hospital. Clin Oncol 1994;6:300–304
Tsang RW, Gospodarowicz MK, Pintilie M, et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol 2003;21:4157–4164
Zelenetz AD, Advani RH, Buadi F, et al. Non-Hodgkin’s lymphoma. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2006;4:258–310
Sippel RS, Gauger PG, Angelos P, et al. Palliative thyroidectomy for malignant lymphoma of the thyroid. Ann Surg Oncol 2002;9:907–911
Noppen M, Poppe K, D’Haese J, et al. Interventional bronchoscopy for treatment of tracheal obstruction secondary to benign or malignant thyroid disease. Chest 2004;125:723–730
Heinrich S, Schager M, Rousson V, et al. Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg 2006;243:154–168
Davis TA, Grillo-Lopez AJ, White CA, et al. Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin’s lymphoma: safety and efficacy of re-treatment. J Clin Oncol 2000;18:3135–3143
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mack, L.A., Pasieka, J.L. An Evidence-Based Approach to the Treatment of Thyroid Lymphoma. World J Surg 31, 978–986 (2007). https://doi.org/10.1007/s00268-005-0768-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-005-0768-z